..
By Jonathan Corum and Carl Zimmer
Updated Dec. 9, 2020
The German company BioNTech partnered with Pfizer to develop and test a coronavirus vaccine known as BNT162b2. A clinical trial demonstrated that the vaccine has an efficacy rate of 95 percent in preventing Covid-19.
Read the article here:
https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html?smid=tw-share
